ELI LILLY & Co - 8-K Filing
Eli Lilly's annual shareholder meeting on May 4, 2026, resulted in the election of four directors with over 89% support for each nominee. Shareholders approved executive compensation (731.9 million votes 'for') and ratified Ernst & Young as auditor. Proposals to eliminate classified board structure, supermajority voting provisions, a policy requiring an independent chair, and a lobbying report were all rejected, receiving less than 58% support in each case. (Items: 5.07 Submission of Matters to a Vote of Security Holders)
Tickers: $LLY